Barcelona, 27 March 2024 – The EBMT proudly commemorates its 50th anniversary, marking five decades of transformative advancements in the field of hematopoietic cell transplantation (HCT) and cellular therapy. More than 5,000 healthcare professionals will gather from the 14th to the 17th of April, 2024, at the Scottish Event Campus in Glasgow for this special edition and they will immerse themselves in cutting-edge scientific content, network with their peers from across the globe, and be part of a community that is driving innovation and change.
In 1974, a small group of visionary clinicians and scientists, Jon van Rood, Bruno Speck, Dick van Bekkum, Eliane Gluckman and others started a joint discussion on bone marrow transplantation and set the start of the EBMT. Over the past fifty years, EBMT has facilitated groundbreaking discoveries, revolutionised clinical practices, and improved outcomes for countless patients battling haematological disorders and malignancies.
From pioneering techniques in donor selection and graft engineering to optimising conditioning regimens and post-transplant care, EBMT has been instrumental in advancing the science and practice of HCT. Through its extensive network of more than 7,000 members, collaborators, and affiliated organisations spanning across Europe and beyond, EBMT continues to drive progress in research, education, and patient care.
As EBMT commemorates its golden jubilee, it reflects not only on its rich history but also on the promising future ahead. With ongoing developments in cellular immunotherapy, gene editing technologies, and personalised medicine, EBMT remains steadfast in its commitment to fostering innovation, collaboration, and excellence in the field.
To mark this milestone anniversary, EBMT will host a series of celebratory events during the Annual Meeting in Glasgow and throughout the year, including a lecture from Eliane Gluckman at the Opening Ceremony, special sessions, publications, an anniversary video highlighting key achievements and future directions in blood and marrow transplantation.
Anna Sureda, President of EBMT, comments: "The 50th anniversary of EBMT is a testament to the dedication, passion, and resilience of our community. As we celebrate this historic milestone, we renew our commitment to excellence, innovation, and collaboration, shaping the future of HCT and cellular therapy for generations to come."
Join EBMT in celebrating fifty years. For more about the 50th Annual Meeting of the EBMT, visit https://www.ebmt.org/annual-meeting-2024
About the EBMT
The EBMT is a non-profit medical and scientific organisation established in 1974 which hosts a unique patient registry providing a pool of data to perform studies and assess new trends. We aim to be the connection between patients, researchers and other stakeholders to anticipate the future of cellular and stem cell-based therapies. Our community of healthcare professionals is focused on innovation, research and the advancement of these fields to save and improve the lives of patients with blood-related disorders. Visit www.ebmt.org to learn more about membership, JACIE accreditation, educational opportunities and how to get involved.
Follow @TheEBMT on X, LinkedIn, Facebook and YouTube